Figure 1.
Serum concentrations of soluble vascular endothelial growth factor receptor 2 (sVEGFR2) before and after elpamotide vaccination. Serum samples were collected at baseline (day 1) as well on days 8 and 29 for determination of sVEGFR2 concentration. *P = 0.026 (paired t‐test) for comparison of the mean values for nine patients between days 1 and 29.